Podcast #18 · 10 Jun 2025
Intermediate Risk NMIBC: Patient-Centered Treatment Strategies
- Bladder Cancer
- Urologic Oncology
- Non-Muscle Invasive Bladder Cancer (NMIBC)
- Medical Oncology
- Transurethral Resection of Bladder Tumor (TURBT)
- Intravesical Therapy
- In-Office Procedures
Counseling patients with intermediate-risk non-muscle invasive bladder cancer can be complex, with a wide range of treatment options and care pathways. In this episode of BackTable, urologic oncologists Dr. Ruchika Talwar and Dr. Kelly Bree explore how to approach this challenge with clarity and compassion.
This podcast is supported by an educational grant from UroGen Pharma. UGN-102 was approved by the FDA on June 12, 2025.